Paper7205804
The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: A comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives.
Ramcharan S and 3 others. J Reprod Med, 1980. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: A comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives. Papers, record 7205804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7205804
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
The Walnut Creek Contraceptive Drug Study. A prospective study of the side effects of oral contraceptives. Volume III, an interim report: A comparison of disease occurrence leading to hospitalization or death in users and nonusers of oral contraceptives.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Contraceptives, Oral | Major topic |
| Adolescent | |
| Adult | |
| California | |
| Female | |
| Humans | |
| Middle Aged | |
| Prospective Studies |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41020076 | Recent investigations on the impact of levonorgestrel and 17β-ethinylestradiol on melanoma. | J Med Life | 2025 | https://conductscience.org/library/papers/41020076 | PubMed |
| 34356998 | Impact of Contraception on Uterine Fibroids. | Medicina (Kaunas) | 2021 | https://conductscience.org/library/papers/34356998 | PubMed |
| 26744813 | Epidemiology of Uterine Fibroids: From Menarche to Menopause. | Clin Obstet Gynecol | 2016 | https://conductscience.org/library/papers/26744813 | PubMed |
| 26528056 | Management of endometrial modifications in perimenopausal women. | Clujul Med | 2015 | https://conductscience.org/library/papers/26528056 | PubMed |
| 24782304 | Oral contraceptives for functional ovarian cysts. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/24782304 | PubMed |
| 24772046 | Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use. | Gastroenterol Hepatol (N Y) | 2013 | https://conductscience.org/library/papers/24772046 | PubMed |
| 22935969 | Impact of sex hormonal changes on tension-type headache and migraine: a cross-sectional population-based survey in 2,600 women. | J Headache Pain | 2012 | https://conductscience.org/library/papers/22935969 | PubMed |
| 22619368 | Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. | Gut | 2013 | https://conductscience.org/library/papers/22619368 | PubMed |
| 22305976 | Menorrhagia. | BMJ Clin Evid | 2012 | https://conductscience.org/library/papers/22305976 | PubMed |
| 21687478 | Four decades of research on hormonal contraception. | Perm J | 2005 | https://conductscience.org/library/papers/21687478 | PubMed |
| 19445802 | Menorrhagia. | BMJ Clin Evid | 2008 | https://conductscience.org/library/papers/19445802 | PubMed |
| 15054460 | Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women's Lifestyle and Health Cohort Study. | Br J Cancer | 2004 | https://conductscience.org/library/papers/15054460 | PubMed |
| 14718211 | Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. | Am J Epidemiol | 2004 | https://conductscience.org/library/papers/14718211 | PubMed |
| 14717620 | Benefits and risks of pharmacological agents used for the treatment of menorrhagia. | Drug Saf | 2004 | https://conductscience.org/library/papers/14717620 | PubMed |
| 12650633 | Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants. | Drug Saf | 2003 | https://conductscience.org/library/papers/12650633 | PubMed |
| 12381211 | Oral contraception and the risk of thromboembolism: what does it mean to clinicians and their patients? | Drug Saf | 2002 | https://conductscience.org/library/papers/12381211 | PubMed |
| 11676302 | Oral contraceptives and cancer: an update. | Drug Saf | 2001 | https://conductscience.org/library/papers/11676302 | PubMed |
| 11085198 | Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms. | Drugs | 2000 | https://conductscience.org/library/papers/11085198 | PubMed |
| 6516346 | Oral contraceptives and venous thrombosis. | West J Med | 1984 | https://conductscience.org/library/papers/6516346 | PubMed |
| 6089441 | Systemic effects of oral contraceptives. | West J Med | 1984 | https://conductscience.org/library/papers/6089441 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7205804
GET https://conductscience.org/api/papers/v1/7205804/cited_by?page=2